Atlas Venture
Status
ACTIVE
Global HQ
Cambridge, United States
Countries of investment
- Germany
- Austria
- Switzerland
- Sweden
- United Kingdom
- Belgium
- Denmark
- Netherlands
- USA
- Canada
- Finland
- Estonia
- Latvia
- Lithuania
- Luxembourg
- Spain
- Czech Republic
- France
- Hungary
- Iceland
- New Zealand
Investment stages
- Pre-Seed
- Seed
- Series A
- Series B
Industries
- Fintech
- Developer Tools
- Consumer Health
- Pharmaceuticals
- Biotech
About
Atlas Venture has been creating and building breakthrough biotechs for over 30 years. The firm partners with the world's best life science entrepreneurs to translate groundbreaking science into lifechanging medicines. Thirty years at the leadingedge of medical innovation and they’re just getting started.
Atlas Venture has been creating and building breakthrough biotechs for over 30 years. The firm partners with the world's best life science entrepreneurs to translate groundbreaking science into lifechanging medicines. Thirty years at the leadingedge of medical innovation and they’re just getting started.
Investment Thesis
Atlas Venture focuses on creating and building breakthrough biotechnology companies. They partner with life science entrepreneurs to translate innovation into novel medicines, emphasizing a collaborative, sciencefirst, patientcentric culture.
Team
Owen Hughes – EntrepreneurinResidence
Executive Chairman
Sail Bio
Jason Rhodes – Partner
Kristen Margeson – Vice President of Investor Relations and Marketing
Portfolio
Horizon Pharma
HotSpot Therapeutics
IFM Therapeutics
Ikena Oncology
Intellia Therapeutics
K36 Therapeutics
Kinaset Therapeutics
Korro Bio
Kymera Therapeutics
Lifordi Immunotherapeutics
Lysosomal Therapeutics
Mariana Oncology